Michael Feld
EVP, Chief Revenue Officer; EVP, CRO & Pres. Life Sciences · 4 filings · Latest: Apr 27, 2026
BECTON DICKINSON & CO
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BDX | Michael Feld | EVP, Chief Revenue Officer | Apr 27, 2026 | Sale | $151.94 | 74 | $11.2K | 21,159 | |
BDX | MICHAEL FELD | — | Apr 27, 2026 | Proposed Sale | $152.14 | 74 | $11.3K | — | |
BDX | Michael Feld | EVP, Chief Revenue Officer | Mar 26, 2026 | Sale | $156.83 | 75 | $11.8K | 21,233 | |
BDX | MICHAEL FELD | — | Mar 26, 2026 | Proposed Sale | $158.27 | 75 | $11.9K | — | |
BDX | Michael Feld | EVP, Chief Revenue Officer | Feb 26, 2026 | Sale | $181.84 | 75 | $13.6K | 21,308 | |
BDX | MICHAEL FELD | — | Feb 26, 2026 | Proposed Sale | $180.96 | 75 | $13.6K | — | |
BDX | Michael Feld | EVP, CRO & Pres. Life Sciences | Jan 26, 2026 | Sale | $202.73 | 75 | $15.2K | 16,431 | |
BDX | MICHAEL FELD | — | Jan 26, 2026 | Proposed Sale | $201.79 | 75 | $15.1K | — | |
BDX | MICHAEL FELD | — | Dec 26, 2025 | Proposed Sale | $196.12 | 74 | $14.5K | — | |
BDX | MICHAEL FELD | — | Dec 1, 2025 | Proposed Sale | $194.02 | 75 | $14.6K | — | |
BDX | MICHAEL FELD | — | Oct 27, 2025 | Proposed Sale | $185.83 | 57 | $10.6K | — | |
BDX | MICHAEL FELD | — | Sep 26, 2025 | Proposed Sale | $180.59 | 58 | $10.5K | — | |
BDX | MICHAEL FELD | — | Aug 22, 2025 | Proposed Sale | $196.63 | 57 | $11.2K | — |